IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.
IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.
复制标题
DOI:
10.1038/s41467-017-00838-4
复制
发表时间:
2017-09-28
影响因子:
16.6
通讯作者:
Egwuagu CE
中科院分区:
文献类型:
--
作者:
Dambuza IM;He C;Choi JK;Yu CR;Wang R;Mattapallil MJ;Wingfield PT;Caspi RR;Egwuagu CE
Interleukin 35 (IL-35) is a heterodimeric cytokine composed of IL-12p35 and Ebi3 subunits. IL-35 suppresses autoimmune diseases while preventing host defense to infection and promoting tumor growth and metastasis by converting resting B and T cells into IL-10-producing and IL-35-producing regulatory B (Breg) and T (Treg) cells. Despite sharing the IL-12p35 subunit, IL-12 (IL-12p35/IL-12p40) promotes inflammatory responses whereas IL-35 (IL-12p35/Ebi3) induces regulatory responses, suggesting that IL-12p35 may have unknown intrinsic immune-regulatory functions regulated by its heterodimeric partner. Here we show that the IL-12p35 subunit has immunoregulatory functions hitherto attributed to IL-35. IL-12p35 suppresses lymphocyte proliferation, induces expansion of IL-10-expressing and IL-35-expressing B cells and ameliorates autoimmune uveitis in mice by antagonizing pathogenic Th17 responses. Recapitulation of essential immunosuppressive activities of IL-35 indicates that IL-12p35 may be utilized for in vivo expansion of Breg cells and autologous Breg cell immunotherapy. Furthermore, our uveitis data suggest that intrinsic immunoregulatory activities of other single chain IL-12 subunits might be exploited to treat other autoimmune diseases. IL-12p35 is common to IL-35 and IL-12, which have opposing effects on inflammation. Here the authors show that the IL-12p35 subunit induces regulatory B cells and can be used therapeutically to limit autoimmune uveitis in mice.
登录
查看更多内容
影响因子:
12.8
作者:
CHAN, CC;CASPI, RR;NUSSENBLATT, RB
通讯作者:
NUSSENBLATT, RB
DOI:
10.1084/jem.20070663
发表时间:
2007-08-06
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Annunziato F;Cosmi L;Santarlasci V;Maggi L;Liotta F;Mazzinghi B;Parente E;Filì L;Ferri S;Frosali F;Giudici F;Romagnani P;Parronchi P;Tonelli F;Maggi E;Romagnani S
通讯作者:
Romagnani S
影响因子:
100.3
作者:
Goriely, Stanislas;Neurath, Markus F.;Goldman, Michel
通讯作者:
Goldman, Michel
DOI:
10.1073/pnas.94.22.12041
发表时间:
1997-10-28
影响因子:
11.1
作者:
Devergne, O;Birkenbach, M;Kieff, E
通讯作者:
Kieff, E
影响因子:
3.7
作者:
Amadi-Obi, Ahjoku;Yu, Cheng-Rong;Egwuagu, Charles E.
通讯作者:
Egwuagu, Charles E.